Live prices

MEDVi vs SnagRx: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher
Reviewed & updated · Cites primary sources (FDA, NEJM, CMS) · Not medical advice
54 providers verified independently·Independent researchHow we rank →

Short answer: MEDVi scores higher on our rubric, 5.7/10 against 3.9/10. Full reasoning, pricing and the cases where the other one wins are below.

MEDVi beats SnagRx overall, scoring 5.7/10 vs 3.9/10. Published pricing is not a like-for-like monthly comparison: MEDVi is $179 first month, then $299/mo; SnagRx is published $69/mo; total not verified. Choose MEDVi for users who want both oral and injectable compounded options in one telehealth program. Choose SnagRx for people comparing the lowest published compounded-semaglutide medication floor who will verify the consultation fee and complete total before paying a brand-new storefront with no independent review record.

A side-by-side look at MEDVi and SnagRx to help you decide. We compare them on:

  • Starting price per month
  • Our overall score, out of 10
  • Medication type, brand-name or compounded
  • Whether they accept insurance
  • Who each one is best for
Higher Rated

MEDVi

#46 of 54
5.7/10

MEDVi offers oral and injectable compounded GLP-1 care. Semaglutide is $179 for month one and $299 for refills. Trustpilot is 4.4/5 across roughly 11,000 reviews, while BBB is F/not accredited. FDA warning letter #721455 concerns misleading labeling and marketing, not an allegation that the medication was unsafe.

Visit MEDVi

SnagRx

#53 of 54
3.9/10

SnagRx is a cash-pay compounded GLP-1 storefront operated by Modern Metabolic Medicine, Inc., the same company behind Embody and RodeoMeds. It advertises compounded semaglutide at $69/mo against a $299 regular price and compounded tirzepatide at $119 against $399, but its terms refer to non-refundable medical consult fees, so those are medication floors rather than verified all-in totals. Shipping is free at a stated 1-2 days. Prescriptions are filled through named partner pharmacies including RedRock Pharmacy. The site launched in January 2026 and its Trustpilot profile, though claimed, still carries no reviews.

Visit SnagRx
FeatureMEDViSnagRx
Our Score5.7/103.9/10
Headline Price$179 first month, then $299/mopublished $69/mo; total not verified
Medication TypeBothCompounded
Insurance AcceptedNoNo
Best ForUsers who want both oral and injectable compounded options in one telehealth programPeople comparing the lowest published compounded-semaglutide medication floor who will verify the consultation fee and complete total before paying a brand-new storefront with no independent review record
Watch out forFDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medicationNo independent review record at all. The Trustpilot profile is claimed and shows zero reviews, so the '125k+ Happy Customers' homepage claim cannot be verified anywhere
Ranking#46#53
Get startedVisit MEDViVisit SnagRx

Pros & Cons Compared

MEDVi

Pros

  • +One of the few compounded providers offering both oral tablets and injectable semaglutide
  • +Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
  • +Sleek onboarding experience with clear progress tracking through their patient portal
  • +$179 covers the first month of compounded semaglutide on the current Katalys landing, including clinician review, medication and shipping

Cons

  • FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
  • Its third-party records conflict: 4.4/5 across roughly 11,000 Trustpilot reviews, but an F and no accreditation at the BBB
  • The $179 semaglutide price is introductory; the current Katalys landing says refills are $299/mo, making the first-year total $3,468 rather than $2,148
  • Brand-name Wegovy and Zepbound paths add a $99 membership plus the medication cost, which the current landing does not publish; availability can change
  • No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

SnagRx

Pros

  • +The lowest advertised compounded-semaglutide medication floor on this site at $69/mo, if the promotional rate holds; the consultation fee and all-in total remain unresolved
  • +Names its partner pharmacy publicly with a link (RedRock Pharmacy), which most competitors do not do
  • +Free 1-2 day shipping with a stated one-day turnaround from intake to a written prescription
  • +The site markets a locked medication rate with no monthly membership and publishes a separate refund policy; its terms still leave a possible medical consult fee unresolved
  • +States service in all 50 states plus Washington D.C.

Cons

  • No independent review record at all. The Trustpilot profile is claimed and shows zero reviews, so the '125k+ Happy Customers' homepage claim cannot be verified anywhere
  • The $69 price sits under a countdown timer that is a standing feature of the page rather than a dated deadline, next to a 'locked-in for life' claim. The regular price is $299
  • 'Cancel Anytime' appears three times on the homepage, but the terms say cancellation deadlines 'will be disclosed at checkout or in your account'. A deadline you only see after committing is not cancel-anytime
  • 'No Hidden Fees' is contradicted by the terms, which refer to medical consult fees that are not refundable
  • All sales are final once medication is dispensed; refunds are limited to medication not yet shipped where a provider finds you ineligible
  • No named clinicians, no medical director, no published lab or video-visit detail
  • Shares its operating entity with Embody and RodeoMeds. Neither SnagRx nor Embody discloses the relationship on its own site, so a shopper comparing them would not know they are one company
  • Cash-pay only, no insurance billing and no prior-authorisation help

Our Verdict

MEDVi edges out SnagRx with a score of 5.7/10 vs 3.9/10. Published pricing is not a like-for-like monthly comparison: MEDVi is $179 first month, then $299/mo; SnagRx is published $69/mo; total not verified. MEDVi offers both brand-name and compounded medications, giving you more flexibility.

Related comparisons

More head-to-head comparisons involving MEDVi and SnagRx.

Not sure which one is right for you?

Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.